BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35728404)

  • 1. Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression.
    Wang WM; Shen H; Liu ZN; Chen YY; Hou LJ; Ding Y
    Cancer Treat Res Commun; 2022; 32():100592. PubMed ID: 35728404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy and EMT in cancer and metastasis: Who controls whom?
    Gundamaraju R; Lu W; Paul MK; Jha NK; Gupta PK; Ojha S; Chattopadhyay I; Rao PV; Ghavami S
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166431. PubMed ID: 35533903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α.
    Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F
    Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Autophagy Functions Shape the Tumor Microenvironment and Play a Role in Cancer Progression - Implications for Cancer Therapy.
    Bustos SO; Antunes F; Rangel MC; Chammas R
    Front Oncol; 2020; 10():606436. PubMed ID: 33324568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour microenvironment: a non-negligible driver for epithelial-mesenchymal transition in colorectal cancer.
    Han L; Wang S; Wei C; Fang Y; Huang S; Yin T; Xiong B; Yang C
    Expert Rev Mol Med; 2021 Nov; 23():e16. PubMed ID: 34758892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
    Pietilä M; Ivaska J; Mani SA
    Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
    Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
    Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.
    Chen HT; Liu H; Mao MJ; Tan Y; Mo XQ; Meng XJ; Cao MT; Zhong CY; Liu Y; Shan H; Jiang GM
    Mol Cancer; 2019 May; 18(1):101. PubMed ID: 31126310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy modulates FSS-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells.
    Su G; Feng T; Pei T; Yang F; Sun D; Yu H; Wang X; Gao W; He J; Shen Y; Liu X
    Mol Carcinog; 2021 Sep; 60(9):607-619. PubMed ID: 34107107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
    Chockley PJ; Keshamouni VG
    J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
    Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
    Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.
    Li H; Xu F; Li S; Zhong A; Meng X; Lai M
    Cell Adh Migr; 2016 Jul; 10(4):434-46. PubMed ID: 26743180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steps in metastasis: an updated review.
    Majidpoor J; Mortezaee K
    Med Oncol; 2021 Jan; 38(1):3. PubMed ID: 33394200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Glypican-1 in the Tumour Microenvironment.
    Lund ME; Campbell DH; Walsh BJ
    Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Emerging Model for Cancer Development from a Tumor Microenvironment Perspective in Mice and Humans.
    Yamaguchi R; Perkins G
    Adv Exp Med Biol; 2020; 1225():19-29. PubMed ID: 32030645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal-Modulated Epithelial-to-Mesenchymal Transition in Cancer Cells.
    Atiya HI; Gorecki G; Garcia GL; Frisbie LG; Baruwal R; Coffman L
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.